Muhammad Ashfaq
Abbottabad, KP, Pakistan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacist-led educational intervention for rational prescribing and deprescribing of proton pump inhibitors in cancer patients: A quasi-experimental study from Pakistan.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: August 17, 2026
Prevalence of the QT interval prolongation and its risk factors in hospitalized geriatric patients: findings of a single center cross-sectional study in Pakistan.
Journal: BMC geriatrics
Published: December 10, 2024
Comparative assessment of treatment outcomes of empagliflozin add-on metformin and sitagliptin add-on metformin therapies in uncontrolled type 2 diabetes mellitus: findings from an observational study in Pakistan.
Journal: Journal of health, population, and nutrition
Published: December 05, 2024
Long-term proton pump inhibitors therapy and prevalence of hyperprolactinaemia: A cross-sectional study in outpatient gastroenterology clinics.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: July 01, 2024
Long-Term Proton Pump Inhibitor Therapy and its Effect on Endocrine Hormones in Selected Patient Population.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: January 10, 2023
Consumption of proton pump inhibitors in outpatients of Gastroenterology Clinics in Khyber Pakhtunkhwa: evidence of inexpedient use.
Journal: Przeglad gastroenterologiczny
Published: August 12, 2022
Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders.
Journal: Endocrine regulations
Published: April 30, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026